BCP
LLY icon

Berkeley Capital Partners’s Eli Lilly LLY Stock Holding History

Berkeley Capital Partners’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.63M Sell
1,361
-15
-1% -$15.3K 0.34% 57
2026
Q1 		$1.27M Buy
1,376
+65
+5% +$65.9K 0.29% 74
2025
Q4 		$1.41M Buy
1,311
+30
+2% +$28.7K 0.33% 57
2025
Q3 		$977K Buy
1,281
+41
+3% +$30.5K 0.23% 88
2025
Q2 		$967K Sell
1,240
-120
-9% -$93.2K 0.25% 86
2025
Q1 		$1.12M Buy
1,360
+54
+4% +$44.9K 0.31% 72
2024
Q4 		$1.01M Sell
1,306
-2
-0.2% -$1.66K 0.28% 76
2024
Q3 		$1.16M Buy
1,308
+99
+8% +$89K 0.33% 65
2024
Q2 		$1.09M Buy
1,209
+132
+12% +$106K 0.33% 60
2024
Q1 		$838K Buy
1,077
+208
+24% +$148K 0.26% 80
2023
Q4 		$507K Buy
869
+247
+40% +$144K 0.17% 107
2023
Q3 		$334K Buy
+622
New +$321K 0.12% 116

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Berkeley Capital Partners's LLY Position: Q2 2026 in Review

Berkeley Capital Partners reduced its Eli Lilly (LLY) stake by 1.1% in Q2 2026, selling an estimated $15.3K and leaving 1,361 shares worth $1.63M. The position accounts for 0.34% of the portfolio, ranked #57.

Berkeley Capital Partners first reported a position in LLY in Q3 2023 and has held it in 12 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Berkeley Capital Partners held 1,361 shares of Eli Lilly worth $1.63M as of Q2 2026.
  • Berkeley Capital Partners sold 15 Eli Lilly shares in Q2 2026, an estimated $15.3K.
  • Eli Lilly made up 0.34% of Berkeley Capital Partners's portfolio in Q2 2026, its #57 holding.
  • Berkeley Capital Partners first reported a position in Eli Lilly in Q3 2023 and has held it in 12 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Berkeley Capital Partners's 13F filing for Q2 2026, filed 6 Aug 2026.